On June 5, 2017, Resverlogix supported a symposium at the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Congress in Madrid, Spain: "Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?"
Introduction - Vincent M Brandenburg, MD, Aachen, Germany.
Kamyar Kalantar-Zadeh, MD – UC Irvine School of Medicine, Irvine, USA. "BET inhibition in renal and cardiovascular disease: What is the clinical roadmap?"
Marta Ruiz-Ortega – Foundación Jiménez Diaz, Madrid, Spain. "Molecular mechanisms involved in the beneficial effect of BET inhibition in experimental renal disease."
Luis M Ruilope, MD – Hospital 12 de Octubre, Madrid, Spain. "The high risk diabetes patient: What is the need for novel approaches to reduce cardiovascular and renal risk?"
Discussion & Summary - Carmine Zoccali, MD, Reggio Cal, Italy.
Video Presentations & Symposium Highlights can be accessed HERE